More Lackluster Results for Non-Opioid Pain Reliever - Pain News Network

Vertex Pharmaceuticals' suzetrigine showed no more effectiveness than placebo in relieving lumbosacral radiculopathy pain, despite company claims of statistical significance. Vertex plans Phase 3 trials, aiming to minimize placebo impact. Suzetrigine, under FDA review for acute pain, blocks peripheral pain signals without opioid-like effects.